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Purpose. To analyze the epidemiological, clinical, and laboratory characteristics of hemolytic-uremic syndrome (HUS) in
Uberlandia, MG, Brazil. Methods. A historical cohort study was performed encompassing a ten-year period from January 1994
to January 2004 in the Department of Pediatric Nephrology at a full-service hospital; demographic factors, triggering factors, time
of hospitalization, supportive therapy, and disease progression were analyzed. Results. Twenty-seven children aged 5 to 99 months
(median age of 14 months) were studied; 70.4% were male. Of the 27 patients, 77.8% were from urban areas and 18.5% were from
rural areas. Eight of the patients (29.6%) were reported to drink raw milk, and clinical diarrhea was reported in 81.5% of cases.
The most common signs and symptoms were fever and vomiting (85.1%), anuria (63.0%), seizure (33.0%), cardiac involvement
(11.0%), and acute pulmonary edema (7.4%). Dialysis was performed on 20 patients (74%). The mean hospital stay was 24
days (range: 13 to 36 days). While monitoring the patients, 2 died (7.4%), 3 developed chronic kidney disease (11.0%), and 21
(77.8%) developed hypertension. Conclusion. Our results emphasize the possibility of diagnosing HUS as a cause of renal failure
in childhood in both typical (postdiarrheal) and atypical forms and suggest that an investigation of the etiological agent should be
made whenever possible.
1.Introduction
Hemolytic-uremic syndrome (HUS), which is deﬁned by the
occurrence of microangiopathic hemolytic anemia, throm-
bocytopenia, and acute renal failure, was ﬁrst described in
childreninthe1950s[1].InArgentina,thediseaseisendemic
and is the leading cause of acute renal failure as well as
the second leading cause of chronic kidney failure [2]. In
the United States, HUS is the leading cause of renal failure
among children [3, 4].
Since the beginning of May 2011, an unusually high
number of cases of HUS and enterohemorrhagic E. coli
(EHEC) infections have been observed in Germany, with
most cases occurring in the northern part of the country.
Investigations by the German authorities indicate that the
vehicle responsible for the outbreak of the verocytotoxin-
producing E. coli (EAggEC VTEC) O104:H4 is bean and seed
sprouts [5].
In 90% of cases,the etiology of HUS is associated with an
infection by E. coli O157:H7, which is an enterohemorrhagic
bacterium that produces the toxin Shiga, a virulence factor
that is responsible for the intestinal and extraintestinal
clinical manifestations of the disease [1].
HUS is classiﬁed as typical or atypical based on the clin-
ical presentation. The form that is nondiarrheal (atypical)
aﬀects approximately 10% of patients, with no predilection
for age; its etiology can be idiopathic or secondary. The
secondary form is rare in the pediatric population and com-
monly occurs from pulmonary pneumococcal or meningeal
infection. The idiopathic form accounts for almost all pedi-
atric HUS cases that occur without diarrhea. Compared to
the typical (post-diarrheal) form, the nondiarrheal form has
a poorer prognosis and is characterized by upper respiratory
tract symptoms [6].
The postdiarrheal form is considered the classic manifes-
tation of the disease, aﬀecting 90% of patients, who typically
range in age from seven months old to six years old. The
clinical presentation begins with digestive symptoms, and
in the prodromal period, the main symptoms are bloody
diarrhea, pain, abdominal distension, and vomiting [7].2 ISRN Pediatrics
E. coli is commensal with cattle, especially calves and
heifers, however bovine-speciﬁc strains can cause disease in
humans. Transmission of the disease is related to the inges-
tion of contaminated products from raw cow’s milk or rumi-
nant meat, with ground beef being the vector responsible
for more than half of all reported outbreaks. Water and
other food products aﬀected by cattle feces are additional
transmission vectors [8–10].
HUS is a disease that consumes a substantial amount of
health care resources. Approximately 276 to 736 new cases
occur annually in the United States. It is estimated that US$
9 . 4t oU S $2 5 . 2m i l l i o n sa r es p e n te a c hy e a rd u r i n gt h ea c u t e
phase of illness. Every year, 24 to 63 survivors develop early-
stagechronicrenalfailureandrequiretransplantsorconstant
dialysis at an additional cost of US$ 7.5 to US$ 19.1 million
[3, 5].
Epidemiological data on HUS in Brazil are scarce.
However, the literature has demonstrated the importance of
this syndrome in terms of the endemic nature of acute renal
failure in many countries, including Argentina, Canada, and
Germany, as well as descriptions of epidemics such as the
recent epidemic that occurred in Japan due to ingestion of
contaminated vegetables [11, 12].
This study was carried out to analyze the risk factors and
theclinicalandpresentationofHUSinacityinsouthwestern
Brazil.
2. Methods
We conducted a cohort study based on institutional records
of patients treated during a ten-year period (January 1,
1994 to January 31, 2004) in the pediatric nephrology
departmentoftheHospitaldeClinicas,UniversidadeFederal
de Uberlandia, MG, Brazil.
Patients were selected for the study based on an exit
diagnosis of HUS according to the discharge protocol of the
Uniﬁed Health System of the Ministry of Health.
The included cases were cases of children admitted to the
intensive care unit or the inﬁrmary with acute microangio-
pathic hemolytic anemia, renal failure, and thrombocytope-
nia,whicheitherhadorhadnotbeenprecededbyprodromes
(diarrhea or upper respiratory tract infection).
The exploratory variables studied were age, gender,
geographic origin, potential factors for the development of
the disease, total hospitalization time, and the need for
dialysis treatment, while the outcome variables were new
comorbidity and vital status upon hospital discharge. The
ethicsandresearchcommitteeoftheinstitutionapprovedthe
study, and participation in research was requested from the
parents by means of signing an informed consent form.
2.1. Statistical Analysis. Demographic data are presented as
percentages with either means and standard deviations or
medians and 95% conﬁdence intervals when the distribution
was non-normal. The odds ratio was used to comparatively
analyze survivors and non-survivors. A P value of less than
0.05 was considered signiﬁcant.
Table 1: Patient Demographic Characteristics.
N Frequency (%)
Number of patients 27 100
Gender
Female 8 29.6
Male 19 70.4
Age range
<12 months 11 40.7
12–60 months 14 51.9
61–99 months 2 7.4
Residency
Country/unknown 5/1 18.5/3.7
Urban 21 77.8
Source of contamination
Unpasteurized milk 8 29.6
Unknown 19 70.4
Time, days (median)
Duration of hospital stay 24 13–36
Prognoses
Chronic renal disease 3 11.1
Hypertension 21 77.7
Hospital survival 25 92.6
Mortality 2 7.4
3. Results
Of the patients who were treated at the pediatric nephrology
clinic of the institution during the study period, 27 were
diagnosed with HUS. Of these, 81.5% were from urban
areas and 18.5% were from rural areas. The demographic
characteristics of the patients are shown in Table 1.E i g h t
patients (29.6%) were female and nineteen (70.4%) were
m a l e .T h ea g e sr a n g e df r o m5t o9 9m o n t h s( m e d i a na g e1 4
months), with nearly half of the patients (51.9%) between 13
and 16 months of age. The mean length of hospital stay was
25 days (6 to 70 days), and 20 patients (74.1%) underwent
peritoneal dialysis (Table 1).
Analysis of triggering factors showed that diarrhea was
present in 81.5% of patients, followed by upper respiratory
tractinfectionin18.5%andtheabsenceofatriggeringfactor
in11%ofcases.Ingestionofunpasteurizedfoodssuchasraw
milk was reported by eight patients (29.6%) (Table 1).
The most frequent symptoms were fever and vomiting,
which were observed in 23 patients (85.1%). Nine patients
(33.3%) had seizures, three (11.1%) had cardiac involve-
ment, and two patients (7,4%) developed acute pulmonary
edema (Table 2).
During treatment, the use of hemoderivative trans-
fusions was required in 23 cases (85.1%). Support of
renal function through dialysis was undertaken in 20 cases
(74.0%), and 17 patients (63.0%) had cyclesof anuria during
hospitalization (Table 3).
With regard to the outcome, 2 patients (7.4%) died, 3
patients (11%) developed chronic kidney disease, and 21
(77.8%) developed hypertension (Table 1).ISRN Pediatrics 3
Table 2: Temporal analysis related to symptoms beginning before
admission.
Age
Prodrome† Symptoms
<12 months
N = 11
(40.7%)
12–60 months
N = 14
(51.85%)
61–99
months
NN N
0–3 days
Vomiting 0 1 (7%) 1 (50%)
Fever 3 (27.2%) 2 (14.2%) 0
Edema 1 (9%) 0 (64.5%) 0
Oliguria 2 (18.18%) 2 (14.2%) 0
3–6 days
Vomiting 2 (25%) 4 (28.5%) 0
Fever 2 (25%) 5 (35.7%) 0
Edema 1 (12.5%) 2 (14.2%) 0
Oliguria 3 (37.5%) 3 (21.4%) 0
6–8 days
Vomiting 3 (27.2%) 3 (21.4%) 0
Fever 3 (27.2%) 2 (14.2%) 0
Edema 0 0 0
Oliguria 2 (18.18%) 2 (14.2%) 0
>8d a y s
Vomiting 2 (18.18%) 4 (28.5%) 0
Fever 2 (18.18%) 4 (28.5%) 0
Edema 0 0 0
Oliguria 2 (18.18%) 3 (21.4%) 0
†Prodromic period distribution quartiles (Q25–Q75).
Oddsratioforvomitingbetweensurvivorsandnon-survivorswas0.06(95%
conﬁdence interval (CI) 0–1.81) and for edema was 0.14 (95% CI 0.01–
2.81). Odds ratio could not be calculated for the presence of oliguria and
f e v e rb e c a u s et h e r ew e r ei n s u ﬃcient patients to perform this calculation.
4. Discussion
The ﬁrst reported case of HUS in Brazil was described in
1967 by Penna et al. [13]. In Brazil, reporting the occurrence
of HUS is mandatory as established by Brazilian Ministry of
Health Ordinance 993 on September 4, 2000. Despite this,
the incidence of HUS in the country has not been established
due to several factors, including underreporting and under-
diagnosis of the disease in cases of forms with incomplete
manifestation that are diﬃcult to diagnose. A study reported
the clinic and microbiologic features associated with 13
postdiarrheal HUS cases identiﬁed in pediatric intensive
care units in the city of S˜ ao Paulo, Brazil, from January
2001 to August 2005. In this paper, the combined use of
microbiologic and serologic techniques provided evidence of
STEC infection in 92.3% of the HUS cases studied, and the
importanceofO157STECasagentsofHUSinS˜ aoPaulowas
highlighted [14].
In Argentina, there are approximately 400 new cases
reported each year. From 1998 to 2005, the incidence rate
increased from 8.2 to 13.9 cases per 100,000 children under
the age of 5. This is due in part to mandatory reporting to
the national epidemiological surveillance system since 2000,
as required by the Ministry of Health [2].
In the city of Uberlandia, MG, we reported the presence
of 27 cases of HUS, with the vast majority occurring after
an episode of diarrhea. Because 9% to 30% of infections by
Table 3: Clinical variables.
N Frequency (%)
Trigger 22 81.5
Diarrhea
Bloody 10 37
Not bloody 12 44.4
Absent/not related 4/1 14.8/3.7
Airway infection 1 3.7
Pneumonia 1 3.7
Absent/not related 2 3.7
Prodromes
Vomiting 20 74.1
Fever 22 81.5
Edema 4 14.8
Signs and symptoms
Oliguria/anuria 19 70.4
Renal 19 70.4
Congestive heart failure 3 11.1
Convulsion 9 33.3
Acute edema 2 7.4
Hypertension 22 81.5
Dialysis/transfusion 20/23 74.1/85.2
†Interquartile range.
Shigatoxin-producing E.coli(STEC)maydevelopintoHUS,
and90%ofcasesofHUSarecausedbySTEC,wemustalways
be aware of this diagnosis, especially in nursing infants who
have bloody diarrhea.
Our data on the progression of the disease, its overall
treatment, dialysis, and prognosis are generally similar to
those described in the literature [2, 5].
Hematologic manifestations of HUS after diarrhea usu-
ally disappear completely within one to two weeks of onset.
The prognosis is generally favorable, with the resolution
beginning after hematologic improvement. The mortality
rate in the literature is less than 5%, which is slightly lower
than that found in our study (7.4%) [15, 16].
Similar ﬁndings were also observed for permanent
sequelae, such as the development of chronic kidney disease.
This developed in 11% of subjects in this study, while the
literature reports that 5% of patients with typical HUS
develop sequelae. Serious complications aﬀecting the central
nervous system, such as seizures and stroke, are considered
to be factors of unfavorable outcomes and were observed in
4 patients (14.8%) in our series.
With regard to hypertension as a sequela of HUS, the
literaturereportsarateof41.4%;however,weobservedarate
of 77.8%.
Thisincreaseinthemortalityrateandtherateofsequelae
in relation to other studies can be explained by the fact that
our data encompassed both typical and atypical HUS, with
the latter showing a less favorable progression.
In addition to the absence of the prodrome of diarrhea,
children with atypical HUS have a diﬀerent mode of clinical4 ISRN Pediatrics
presentation. According to a study conducted in 1993 on
the clinical manifestations and outcomes of twenty children
who were monitored for twenty years, there were no speciﬁc
prodromes, but a signiﬁcant increase in blood pressure was
observed [17]. The outcome was unfavorable, given that
ﬁve patients died and four developed terminal renal disease.
Among the eleven patients treated with plasmapheresis, all
recovered renal function at an early stage, but ten experi-
enced subsequent clinical deterioration.
As described above, in most patients with typical HUS,
the glomerular ﬁltration rate (GFR) returns to normal.
However, it may remain reduced in 10% to 20% of patients,
suggesting permanent nephron loss [18].
In this study, 11% of patients developed chronic kidney
disease. This rate is consistent with the literature, which
reports the presence of permanent sequelae in 5% to 25%
of cases [19]. The prognosis of HUS has improved partly
due to the early institution of supportive therapy, especially
in intensive care units, as well as dialysis therapy to support
renal function.
Because typical HUS is strongly associated with certain
strains of EHEC that produce Shiga toxin, such as the
O157:H7 strain, prevention of typical HUS relies in part
upon measures taken to reduce the risk of E. coli infection.
Proper food preparation is essential, and an internal
temperature of meat above 155 degrees F (68.3 degrees C) is
necessary to eradicate contamination by EHEC. Establishing
standards and educating the public in proper food prepa-
ration are important public health measures. The identiﬁ-
cation of cases, with an expanded system and more active
surveillance, can lead to early detection of epidemics and the
removal of possible contaminants in food that has not yet
been consumed. For example, molecular epidemiology tech-
niques helped identify an epidemic infection in Connecticut,
which was linked to food from a supermarket. Supervision
of hand washing by children in schools and kindergartens, as
wellastheexclusion ofsymptomatic children, canreducethe
spread from person to person. Hospitalized patients should
be monitored carefully, and universal precautions should be
taken to prevent transmission to health workers [20, 21].
Although laboratory diagnosis of enterohemorrhagic E.
coli infection can be made by stool culture, the bacteria
are only present in the stools for a few days and, even if
present, may not be detected by culture from stool samples.
New diagnostic tools for pathogenic E. coli infection directly
detect Shiga toxins in stool or use DNA probes to detect the
toxin genes in fecal isolates. These assays are not yet clinically
available. Then, the diagnosis of Stx HUS in children is
generally made on clinical grounds from the characteristic
clinical and laboratory ﬁndings previously described: a
prodrome of diarrhea, followed by abrupt onset of the
characteristic triad of microangiopathic hemolytic anemia,
thrombocytopenia, and acute renal injury.
5. Conclusions
Our data call attention to the importance of diagnosing HUS
and of researching the etiological agent whenever possible,
especially in cases of diarrhea.
Due to the severity of the disease and the possibility of
underdiagnosis, there is a need to implement surveillance
measures to control the incidence of STEC infections and
to detect outbreaks or epidemics. Examining antibodies can
greatly help in the diagnosis of STEC infection in HUS
patients in whom stool cultures are negative.
Because typical HUS is strongly associated with certain
strains of EHTC that produce Shiga toxin, such as the
O157:H7 strain, prevention of typical HUS relies in part on
measures taken to reduce the risk of E. coli infection [19, 20].
The prognosis of HUS has improved, due in part to
early institution of supportive therapy, especially in intensive
care units, and to renal replacement therapy using dialysis
procedures.
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